title: Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectin.
abstract: Circadian (8/24 hours) variations in serum nitric oxide (NO), total tissue factor pathway inhibitor (T-TFPI). and E-selectin levels were studied in healthy adults and in subjects with type II diabetes. We postulated a possibility a functional relationship between them because vascular endothelium is the primary site of their synthesis and functions. NO is released by the action of eNO synthase isoform and modulates physiologic responses (e.g., vascular dilation, relaxation, increasing blood flow, inhibition of platelet and white blood cell adhesion); T-TFPI, a coagulation inhibitor, is also released from endothelial cells, and is bound to plasma lipoproteins and to glycosaminoglycans; E-selectin is expressed on endothelial cells after activation by inflammatory cytokines (interleukin-1beta and tumor necrosis factor-alpha) and elevated levels have been reported in a variety of pathologic conditions, including diabetes. We found that obese diabetic subjects had greater mean concentrations of NO and E-selectin than healthy men, 39.25 versus 12.71 microM and 81.51 versus 26.03 ng/mL, respectively. The T-TFPI levels were essentially similar in both groups of men, 47.10 versus 48.76 ng/mL. We observed that the time of peak concentrations of T-TFPI and E-selectin was similar to the timing of NO trough levels, suggesting a possible functional relationship. It may be hypothesized, therefore, that the higher concentrations of NO, unbalanced by increases in T-TFPI and E-selectin, may result in increased vascular wall uptake of lipoproteins in diabetic subjects, who are at greater risk than healthy men for developing diffuse atherosclerosis.
authors.affiliation: Nuclear Medicine Service, VA Medical Center, Hines, Illinois 60141, USA. kanabrocki@aol.com
authors.forename: E L
authors.initials: EL
authors.lastname: Kanabrocki
authors.forename: M
authors.initials: M
authors.lastname: George
authors.forename: R C
authors.initials: RC
authors.lastname: Hermida
authors.forename: H L
authors.initials: HL
authors.lastname: Messmore
authors.forename: M D
authors.initials: MD
authors.lastname: Ryan
authors.forename: D E
authors.initials: DE
authors.lastname: Ayala
authors.forename: D A
authors.initials: DA
authors.lastname: Hoppensteadt
authors.forename: J
authors.initials: J
authors.lastname: Fareed
authors.forename: F W
authors.initials: FW
authors.lastname: Bremner
authors.forename: J L
authors.initials: JL
authors.lastname: Third
authors.forename: P
authors.initials: P
authors.lastname: Shirazi
authors.forename: B A
authors.initials: BA
authors.lastname: Nemchausky
mesh_terms: D000368:Aged; D016022:Case-Control Studies; D002940:Circadian Rhythm; D003920:Diabetes Mellitus / Q000097:blood / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000503:physiopathology*; D019040:E-Selectin / Q000097:blood / Q000502:physiology*; D004730:Endothelium, Vascular / Q000378:metabolism; D006801:Humans; D008074:Lipoproteins / Q000097:blood / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000097:blood / Q000502:physiology*; D009765:Obesity
chemical_list: D019040:E-Selectin; D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor; D009569:Nitric Oxide